Skadden is advising Paratek Pharmaceuticals in the transaction, Hogan Lovells is advising Optinose. Paratek Pharmaceuticals and Optinose, Inc. (NASDAQ:OPTN) have entered into a definitive merger agreement...
Paratek Pharmaceuticals’ Acquisition of Optinose
Creative Science’s Acquisition of Infiniti Medical and Orthomed UK
Skadden and Wilson Sonsini Goodrich & Rosati acted as legal counsel to Infiniti Medical. Creative Science, a CIMA Animal Health company, announced the acquisition of Infiniti...
Novartis’ Acquisition of MorphoSys
Skadden advised MorphoSys AG in the deal. MorphoSys AG has entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG (hereinafter collectively referred...
Numerix’s Acquisition of PolyPaths
Willkie Farr & Gallagher LLP served as legal counsel to Numerix, while Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel to PolyPaths. Numerix,...
ARYA Sciences Acquisition Corp IV’s Acquisition of Amicus Therapeutics’ Gene Therapy Business
Skadden, Arps, Slate, Meagher & Flom, Wilson Sonsini Goodrich & Rosati and Troutman Pepper Hamilton Sanders represented Amicus Therapeutics, while Kirkland & Ellis represented ARYA IV...
Alcon’s Acquisition of U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Skadden, Arps, Slate, Meagher & Flom LLP advised Alcon on the deal. Alcon, the global leader in eye care dedicated to helping people see brilliantly, has...